| Long name | Cy5, 5 Conjugated, CITED1/ABCC1 Polyclonal Antibody |
| Category | Conjugated Primary Antibodies |
| Conjugation | Cy5, 5, 5, Cy5 |
| Host Organism | Rabbit (Oryctolagus cuniculus) |
| Target Antigen | CITED1/ABCC1 |
| Specificity | May cross react with CITED2, This is a highly specific antibody against CITED1/ABCC1 |
| Modification | Unmodified |
| Modification site | None |
| Clonality | Polyclonal |
| Clone | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen_range | 130-180/193 |
| Subcellular location | Nucleus, Cytoplasm |
| Source | KLH conjugated synthetic peptide derived from human CITED1/ABCC1 |
| Gene ID number | 10370 |
| Swiss Prot | Q99967 |
| Tested applications | IF(IHC-P) |
| Recommended dilutions | IF(IHC-P)(1:50-200) |
| Crossreactivity | Mouse, Rat, Human |
| Crossreactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background | Acts also as a transcriptional corepressor, Acts as a bridge, Associates with chromatin to the PITX2 P1 promoter region, Enhances estrogen-dependent transactivation mediated by estrogen receptors, Participates in sex determination and early gonad development by stimulating transcription activation of SRY, Plays a role in controlling left-right patterning during embryogenesis, Plays an essential role in differentiation of the adrenal cortex from the adrenogonadal primordium (AGP), Positively regulates TGF-beta signaling through its association with the SMAD/p300/CBP-mediated transcriptional coactivator complex, Stimulates the peroxisome proliferator-activated receptors PPARA transcriptional activity, interferes with the binding of the transcription factors HIF1A or STAT2 and the p300/CBP transcriptional coactivator complex, linking TFAP2 transcription factors and the p300/CBP transcriptional coactivator complex in order to stimulate TFAP2-mediated transcriptional activation, potentiates transcriptional activation of NODAL-mediated gene transcription in the left lateral plate mesoderm (LPM), stimulates WT1-mediated transcription activation thereby up-regulating the nuclear hormone receptor NR5A1 promoter activity, Transcriptional coactivator of the p300/CBP-mediated trancription complex |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission | 675nm/694nm |
| Properties | Cy5 antibodies are excited by the 650-nanometer wave of an argon laser and detected at a 670-nanometer captor, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Conjugated | These antibodies are excite for emission at 678nm and detected at a 694 , nm wavelengths |
| Gene target | CITED1/ABCC1 Conjugated |
| Short name | Conjugated, CITED1/ABCC1 Antibody |
| Technique | antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label | 5, Cy5 |
| Alternative name | 1/ABCC1 (Antibody to), cyanine 5, including L-gutamic acid/L-aspartic acid-rich carboxy-terminal domain, 5 coupled, Cbp/p300-interacting transactivator |
| Alternative technique | antibodies |
| Alternative to gene target | 1, CITED1 and IDBG-635694 and ENSBTAG00000045925 and 282182, CITED1 and IDBG-76674 and ENSG00000125931 and 4435, Cited1 and IDBG-164976 and ENSMUSG00000051159 and 12705, DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0006913 and nucleocytoplasmic transport and biological process this GO :0006915 and apoptotic process and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007420 and brain development and biological process this GO :0008022 and protein C-terminus binding and molecular function this GO :0008283 and cell proliferation and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0030178 and negative regulation of Wnt signaling pathway and biological process this GO :0030318 and melanocyte differentiation and biological process this GO :0030511 and positive regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0032496 and response to lipopolysaccharide and biological process this GO :0032868 and response to insulin and biological process this GO :0034097 and response to cytokine and biological process this GO :0034341 and response to interferon-gamma and biological process this GO :0042438 and melanin biosynthetic process and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043473 and pigmentation and biological process this GO :0043524 and negative regulation of neuron apoptotic process and biological process this GO :0043627 and response to estrogen and biological process this GO :0044212 and transcription regulatory region DNA binding and molecular function this GO :0045668 and negative regulation of osteoblast differentiation and biological process this GO :0045892 and negative regulation of transcription, DNA-templated and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0050693 and LBD domain binding and molecular function this GO :0051591 and response to cAMP and biological process this GO :0060231 and mesenchymal to epithelial transition and biological process this GO :0060395 and SMAD protein signal transduction and biological process this GO :0060711 and labyrinthine layer development and biological process this GO :0060712 and spongiotrophoblast layer development and biological process this GO :0070410 and co-SMAD binding and molecular function this GO :0070555 and response to interleukin-1 and biological process this GO :0070669 and response to interleukin-2 and biological process this GO :0070670 and response to interleukin-4 and biological process this GO :0070741 and response to interleukin-6 and biological process this GO :0071104 and response to interleukin-9 and biological process this GO :0071105 and response to interleukin-11 and biological process this GO :0071107 and response to parathyroid hormone and biological process this GO :0071559 and response to transforming growth factor beta and biological process, MSG1, co-SMAD binding, nuclei, this GO :0000578 and embryonic axis specification and biological process this GO :0001570 and vasculogenesis and biological process this GO :0001656 and metanephros development and biological process this GO :0001658 and branching involved in ureteric bud morphogenesis and biological process this GO :0001890 and placenta development and biological process this GO :0003340 and negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis and biological process this GO :0003682 and chromatin binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0003713 and transcription coactivator activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006351 and transcription, this GO :0003682: chromatin binding, this GO :0003682: chromatin binding and also this GO :0003700: sequence-specific DNA binding transcription factor activity and also this GO :0003713: transcription coactivator activity and also this GO :0005515: protein binding and also this GO :0008022: protein C-terminus binding and also this GO :0042803: protein homodimerization activity and also this GO :0044212: transcription regulatory region DNA binding and also this GO :0050693: LBD domain binding and also this GO :0070410: co-SMAD binding, this GO :0003700: sequence-specific DNA binding transcription factor activity, this GO :0003713: transcription coactivator activity, this GO :0005515: protein binding, this GO :0008022: protein C-terminus binding, this GO :0042803: protein homodimerization activity, this GO :0044212: transcription regulatory region DNA binding, this GO :0050693: LBD domain binding, this GO :0070410: co-SMAD binding, with Glu/Asp-rich carboxy-terminal domain, Cbp/p300-interacting transactivator |
| Identity | 1986 |
| Gene | CITED1 |
| Long gene name | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1 |
| Synonyms gene | MSG1 |
| Synonyms gene name | 1 , Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain |
| Locus | Xq13, 1 |
| Discovery year | 1998-03-27 |
| GenBank acession | U65092 |
| Entrez gene record | 4435 |
| Pubmed identfication | 8901575 9721210 |
| RefSeq identity | NM_004143 |
| Havana BLAST/BLAT | OTTHUMG00000021812 |
| Locus Specific Databases | Mental Retardation database |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue